Benign paroxysmal positional vertigo differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 270: Line 270:
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +/−
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +/−
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* History of migraine headaches
* History of [[migraine headaches]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |−
| style="background: #F5F5F5; padding: 5px; text-align: center;" |−
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* They may have white-matter hyperintensities (WMHs) on MRI
* They may have [[White matter|white-matter]] hyperintensities (WMHs) on [[MRI]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* ICHD-3 criteria
* ICHD-3 criteria
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* It may be associated with anxiety and depression
* It may be associated with [[anxiety]] and [[depression]]
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Epileptic vertigo
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Epileptic vertigo
Line 285: Line 285:
| style="background: #F5F5F5; padding: 5px; text-align: center;" |−
| style="background: #F5F5F5; padding: 5px; text-align: center;" |−
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* They may experience loss of consciousness and motor/sensory problems
* They may experience [[loss of consciousness]] and motor/sensory problems
| style="background: #F5F5F5; padding: 5px; text-align: center;" |−
| style="background: #F5F5F5; padding: 5px; text-align: center;" |−
| style="background: #F5F5F5; padding: 5px; text-align: center;" |−
| style="background: #F5F5F5; padding: 5px; text-align: center;" |−
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* EEG
* [[EEG]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* They response well to anti-seizure drugs
* They response well to anti-seizure drugs
Line 299: Line 299:
| style="background: #F5F5F5; padding: 5px; text-align: center;" |−
| style="background: #F5F5F5; padding: 5px; text-align: center;" |−
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Lhermitte's sign
* [[Lhermitte's sign]]
* Spasticity
* [[Spasticity]]
* Increased [[reflexes]]  
* Increased [[reflexes]]  
* [[Internuclear ophthalmoplegia]]
* [[Internuclear ophthalmoplegia]]
* Optic neuritis
* [[Optic neuritis]]
* [[Gait disturbance]]
* [[Gait disturbance]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Elevated concentration of [[CSF]] [[oligoclonal bands]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Elevated concentration of [[CSF]] [[oligoclonal bands]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Brain atrophy and some [[contrast]] enhancing plaques on CT scan
* [[Cerebral atrophy|Brain atrophy]] and some [[contrast]] enhancing plaques on [[CT scan]]
* Cerebral plaques disseminating in space and time on MRI
* Cerebral plaques disseminating in space and time on [[MRI scan|MRI]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* [[History and Physical examination|History and physical examination]]
* [[History and Physical examination|History and physical examination]]
Line 323: Line 323:
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +
| style="background: #F5F5F5; padding: 5px; text-align: center;" | +
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Papilledema
* [[Papilledema]]
* Focal neurological deficits
* [[Focal neurological deficits]]
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Cerebral spinal fluid ([[CSF]]) may show cancerous cells
| style="background: #F5F5F5; padding: 5px; text-align: center;" |Cerebral spinal fluid ([[CSF]]) may show cancerous cells
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* On CT scan most of the brain tumors appears as a hypodense mass lesions
* On [[CT scan]] most of the [[brain tumors]] appears as a hypodense mass lesions
* On MRI most of the brain tumors appears as a hypointense or isointense on T1-weighted scans, or hyperintense on T2-weighted MRI.
* On [[MRI scan|MRI]] most of the [[brain tumors]] appears as a hypointense or isointense on T1-weighted scans, or hyperintense on T2-weighted [[MRI contrast agent|MRI]].
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Imaging
* [[Imaging]]


* Biopsy
* [[Biopsy forceps|Biopsy]]
| style="background: #F5F5F5; padding: 5px;" |
| style="background: #F5F5F5; padding: 5px;" |
* Patieny may experience  [[headache]], [[seizures]], visual changes and changes in personality, mood and concentration
* Patieny may experience  [[headache]], [[seizures]], [[Visual disturbance|visual changes]] and changes in [[personality]], [[mood]] and [[concentration]]
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Crebellar infarction/hemorrhage
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Crebellar infarction/hemorrhage

Revision as of 14:50, 11 April 2019

For the WikiDoc page for this topic, click here

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Fahimeh Shojaei, M.D.

Overview

[Disease name] must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as [differential dx1], [differential dx2], and [differential dx3].

OR

[Disease name] must be differentiated from [[differential dx1], [differential dx2], and [differential dx3].

Differentiating [Disease name] from other Diseases

[Disease name] must be differentiated from other diseases that cause [clinical feature 1], [clinical feature 2], and [clinical feature 3], such as [differential dx1], [differential dx2], and [differential dx3].

OR

[Disease name] must be differentiated from [differential dx1], [differential dx2], and [differential dx3].

OR

As [disease name] +in a variety of clinical forms, differentiation must be established in accordance with the particular subtype. [Subtype name 1] must be differentiated from other diseases that cause [clinical feature 1], such as [differential dx1] and [differential dx2]. In contrast, [subtype name 2] must be differentiated from other diseases that cause [clinical feature 2], such as [differential dx3] and [differential dx4].

Differentiating [disease name] from other diseases on the basis of [symptom 1], [symptom 2], and [symptom 3]

On the basis [symptom 1], [symptom 2], and [symptom 3], [disease name] must be differentiated from [disease 1], [disease 2], [disease 3], [disease 4], [disease 5], and [disease 6].

Diseases Clinical manifestations Para-clinical findings Gold standard Additional findings
Symptoms Physical examination
Lab Findings Imaging
Acute onset Recurrency Nystagmus Hearing problems
Peripheral
BPPV + + +/−
Vestibular neuritis + +/− + /−

(unilateral)

  • + Head thrust test
HSV oticus + +/− +/− + VZV antibody titres
Meniere disease +/− + +/− + (Progressive)
Labyrinthine concussion + +
Perilymphatic fistula +/− + +
  • CT scan may show fluid around the round window recess
Semicircular canal

dehiscence syndrome

+/− + +

(air-bone gaps on audiometry)

Vestibular paroxysmia + + +/−

(Induced by hyperventilation)

Cogan syndrome + +/− + Increased ESR and cryoglobulins
  • In CT scan we may see calcification or soft tissue attenuation obliterating the intralabyrinthine fluid spaces
Vestibular schwannoma + +/− +
Otitis media + +/− Increased acute phase reactants
Aminoglycoside toxicity + +
Recurrent vestibulopathy +
  • It may happen infrequently, every one to two years
  • It may be associated with nausea and vomiting
  • It may overlap with vestibular migraine
Central
Vestibular migrain + +/− +/−
  • ICHD-3 criteria
Epileptic vertigo + +/−
  • They response well to anti-seizure drugs
Multiple sclerosis + +/− Elevated concentration of CSF oligoclonal bands
  • MS is at least two times more common among women than men
  • The onset of symptoms is mostly between the age of fifteen to forty years, rarely before age fifteen or after age sixty
Brain tumors +/− + + + Cerebral spinal fluid (CSF) may show cancerous cells
  • On CT scan most of the brain tumors appears as a hypodense mass lesions
  • On MRI most of the brain tumors appears as a hypointense or isointense on T1-weighted scans, or hyperintense on T2-weighted MRI.
Crebellar infarction/hemorrhage +
Brain stem ischemia +
Chiari malformation
Parkinson

References

Template:WH Template:WS